Improved Insurance Coverage Increased Biosimilar Semglee's Market Share After The FDA's Interchangeability Designation

Interchangeability, a Food and Drug Administration (FDA) designation allowing pharmacists to substitute a biosimilar for its branded originator at the point of sale, is intended to increase biosimilar adoption. However, little is known about the relationship between interchangeability and biosimilar...

Full description

Bibliographic Details

Published in:	Health affairs (Millwood, Va.) Vol. 44; no. 11; p. 1417
Main Authors:	Kakani, Pragya, Katcher, Bradley A, Maini, Luca
Format:	Journal Article
Language:	English
Published:	United States 01.11.2025
Subjects:	Biosimilar Pharmaceuticals - economics Biosimilar Pharmaceuticals - therapeutic use Health Benefit Plans, Employee - statistics & numerical data Humans Insurance Coverage - statistics & numerical data Interrupted Time Series Analysis Medicaid - statistics & numerical data United States United States Food and Drug Administration United States
ISSN:	2694-233X, 2694-233X
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!